National Medical Products Administration, Provisions for the Oversight of the Production of Export Pharmaceuticals (Draft for Comments)

国家药品监督管理局出口药品生产监督管理规定 (征求意见稿)

Export pharmaceuticals commissioned for production from a foreign pharmaceutical manufacturer may not be sold and used in the PRC

1 minute readAugust 26, 2024 at 02:07 PM
By
Susan Mok

Issued: August 1, 2024

Main contents: The Provisions detail information relating to acceptance of a commission for production from a foreign1 pharmaceutical manufacturer

A Subscription is Required to Access this Content

Subscribe to China Law & Practice today for:

  • ✓ A database of 3000+ essential documents, including key PRC laws translated into English
  • ✓ Newsletters with business-critical and sector-specific updates
  • ✓ Premium mobile access with timely analysis on China's fast-changing market

Already a Subscriber? Log In. Sign In Now

Questions? Contact us at [email protected] | 1-855-808-4530 (Americas) | 44(0) 800 098 386009 (UK & Europe)